Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 38.24M P/E - EPS this Y 39.10% Ern Qtrly Grth -
Income -69.67M Forward P/E -0.82 EPS next Y -5.70% 50D Avg Chg -3.00%
Sales - PEG -0.14 EPS past 5Y - 200D Avg Chg -17.00%
Dividend N/A Price/Book 0.22 EPS next 5Y 5.20% 52W High Chg -72.00%
Recommedations 2.50 Quick Ratio 8.35 Shares Outstanding 41.50M 52W Low Chg 30.00%
Insider Own 6.71% ROA -24.61% Shares Float 21.21M Beta 1.09
Inst Own 50.89% ROE -41.05% Shares Shorted/Prior 37.83K/68.90K Price 0.97
Gross Margin - Profit Margin - Avg. Volume 110,488 Target Price 2.83
Oper. Margin - Earnings Date May 8 Volume 33,280 Change -4.66%
About Achilles Therapeutics plc

Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Achilles Therapeutics plc News
04/04/24 Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
04/04/24 Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
03/07/24 Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?
02/09/24 Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?
02/05/24 Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
01/24/24 Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
12/18/23 Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
11/13/23 Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
10/24/23 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
09/29/23 Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?
09/22/23 Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
09/22/23 Are Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?
09/13/23 Waters (WAT) Walk-Up Solutions Boost Bioprocess Development
09/06/23 Is KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?
08/10/23 Jazz (JAZZ) Beats on Q2 Earnings & Sales, Raises '23 View
08/04/23 Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
06/12/23 Achilles Therapeutics to Present at Upcoming Conferences
05/21/23 3 Stocks With 1,000% Upside Potential
05/10/23 Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
05/10/23 Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
ACHL Chatroom

User Image Happy_Feet19 Posted - 04/30/24

$ACHL Doesn't look like the interim data was to exciting per maket reaction. Is anybody expecting a stock pop on 2nd clinical Update by 2H2024?

User Image InYourFaceTomSelleck Posted - 04/27/24

$ACHL can't get much worse than this.... can it?

User Image Magic8BallResponse Posted - 04/26/24

$ACHL Maybe Autolus can use some cash..... lol

User Image BiotechSwingz Posted - 04/25/24

$ACHL time to buy this again. Syncona and 220% until netcash. Nothing more to say.

User Image Trader_Orca Posted - 04/25/24

$ACHL short close❤️

User Image Bobby_J_Bomb Posted - 04/25/24

$KZR $ACHL Loading both at bottom here!!

User Image InYourFaceTomSelleck Posted - 04/25/24

$ACHL where's the news? So quiet

User Image js3456 Posted - 04/19/24

$ACHL biggest concern - syncona lets cash dwindle, sandbags next update…and scoops this up for pennies. but they could just scoop it up now for cash value and make everyone happy 🤔

User Image Trader_Orca Posted - 04/19/24

$ACHL burning cash only ~1$ net cash end of 2024

User Image GPS_OS_21_vs_SOC_5 Posted - 04/18/24

$SLS - Walker Bill aka @telomerase lying on Yahoo about 009 being "just as toxic as other so called cdk9 inhibitors, cured lied again." Pure BullSH The Lowlife Lied about 009 being toxic the morning SLS published Safety Data at ASH confirming 009 Was Safe - No DLT's and No Serious Side Effects at all - not one. If $VINC had published the same data about VIP152/enitociclib, they would still be funding trials and have a mcap of $1B, (VINC was at $700M for a hot minute based solely on there one and only asset at the time, before the tox became evident) Bottom y Screen shot, the pathological liar, lies about lying about 009. $KRON $MAIA $ACHL @SocioCobb @BlackRockBee @FrankWhite2725 @_diagio @Selwot now you know bill is a lowlife - Fact is - The scumbag Knows 009 is worth 10x the whole SLS MCAP

User Image telomerase Posted - 04/18/24

$ACHL LIQUIDATE THIS CASH FIRE

User Image Whtmtn Posted - 04/15/24

$ACHL another $gnca clone bites the dust.

User Image Magic8BallResponse Posted - 04/15/24

$ACHL Maybe $ADAP make better use of this cash

User Image Magic8BallResponse Posted - 04/13/24

$ACHL Return cash. Not a strong enough signal

User Image InYourFaceTomSelleck Posted - 04/11/24

$ACHL I smell a rebound!

User Image rp6577 Posted - 04/11/24

$ACHL looks like it might trend back up towards $1

User Image Sil12345 Posted - 04/11/24

$ACHL tought that it will pump back but have to look diffrent one

User Image Sil12345 Posted - 04/11/24

$ACHL dead

User Image Sil12345 Posted - 04/11/24

$ACHL so, why so quiet?

User Image RallyRaider Posted - 04/10/24

$ACHL nobody wants a piece of this. Has TONS of cash and noone cares. Stock price would go up if company announced to yolo cash on NVDA OTM calls.

User Image InYourFaceTomSelleck Posted - 04/10/24

$ACHL nobody's home

User Image MrLuckyStock Posted - 04/09/24

@Ready321 33% down form the time you posted and you are calling me rug puller. Indeed you are a bad luck. $ACHL

User Image Drugtrade Posted - 04/09/24

$ACHL glad I dumped in .90s. Only way I could have done better if I had never bought

User Image InYourFaceTomSelleck Posted - 04/08/24

$ACHL .65 is in a few weeks and should last about a month Imo. Then it'll come back up to $1.30 or so

User Image rp6577 Posted - 04/08/24

$ACHL might be the start of a little recovery

User Image telomerase Posted - 04/08/24

$ACHL the CEO of ACHL has HIS retirement plan... it's to collect an enormous salary while running "trials" that don't work. What's YOURS?

User Image InYourFaceTomSelleck Posted - 04/08/24

$ACHL dead duck. Come on!

User Image Rohtan Posted - 04/05/24

$ACHL expect it to go below .70s before it starts going up. No news expected now in near term.

User Image Ulong Posted - 04/05/24

$ACHL Dr Iraj Ali, Chief Executive Officer of Achilles Therapeutics: “Looking ahead to 2024, we will evaluate cNeT persistence and clinical activity in patients with enhanced host conditioning, and we plan to report a meaningful data update in the second half of 2024. Our financial position remains strong with more than $131 million in cash, which supports operations through 2025, including the completion of the ongoing Phase I/IIa trials.” https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-reports-fourth-quarter-and-year-end-2023

User Image InYourFaceTomSelleck Posted - 04/05/24

$ACHL honestly I'd be happy with $1.13 so I can get out

Analyst Ratings
Chardan Capital Buy Apr 5, 24
Piper Sandler Neutral Apr 5, 24
B of A Securities Underperform Dec 14, 23
Chardan Capital Buy Aug 7, 23
Chardan Capital Buy May 11, 23
Chardan Capital Buy Dec 7, 22
Piper Sandler Overweight Dec 7, 22
JP Morgan Underweight Apr 26, 21
B of A Securities Buy Apr 26, 21